Connect with us

Pregnancy

Nuvo and Sheba Medical Centre collaboration brings AI into pregnancy care

The early-stage collaboration includes the evaluation of a new virtual care regimen for managing gestational diabetes

Published

on

An FDA-approved remote pregnancy monitoring platform has announced a collaboration agreement with Israel’s Sheba Medical Centre.

The Nuvo Group is the creator of INVU, a pregnancy monitoring and management system.

The first phase of its partnership with the Sheba Medical Centre consisted of a pilot programme around gestational diabetes management, in which medically necessary non-stress tests (NSTs) were shifted to home-based remote monitoring using INVU rather than conducting traditional monitoring in a physical medical facility.

A NST is a common prenatal test used to check on a baby’s health, during which the baby’s heart rate is monitored to see how it responds to the baby’s movements.

As part of the partnership, participating physicians prescribed INVU to expectant mothers, who wore the sensor band from home during virtual visits.

During these virtual visits anchored by the hospital’s Sheba BEYOND, virtual hospital platform, a live reading allowed the expectant mother to access data and insights via the INVU app, while the provider received more detailed foetal and maternal surveillance that OB/GYNs are accustomed to receiving during in-office visits.

The pilot programme also included the use of several other telemedicine solutions alongside INVU, including a remote ultrasound device, glucose monitoring, and home urinalysis kit.

In addition to offering a safe and proven regimen for managing gestational diabetes, the programme aimed to help patients and providers save time and improve the overall care experience.

For the next phase of the partnership, Nuvo and Sheba intend to work together to integrate the INVU platform into the hospital’s standard of care protocols, planning to utilise data collected from the pilot programme to develop new AI tools to advance pregnancy care management and lower costs.

“Our long term goal is to provide pregnant women with the best possible maternal-foetal surveillance wherever they are – in our clinics, at the comfort of their home or during their work day,” says Dr Avi Tsur, high-risk pregnancy expert and director of Sheba’s Women’s Health Innovation Center and Sheba BEYOND’s Obstetrics & Gynaecology Beyond tele-health platform.

“The INVU foetal monitoring solution has the potential to be a catalyst of transformative care in an area of medicine that has been lagging in innovation and new approaches for decades. I hope this pilot is only the beginning.”

Dr Galia Barkai, director of Sheba BEYOND, says : “Sheba Beyond is constantly adopting cutting-edge technologies, which are enabling patients to receive the best care in the comfort of their homes. This collaboration is yet another step towards our goal to bring high level, hospital care, to everyone, everywhere.”

Kelly Londy, CEO of Nuvo Group, says it is an honour to collaborate with Sheba.

She adds: “The INVU platform is particularly beneficial for high-risk pregnancies that would otherwise require frequent in-office visits, which we know can become burdensome on all sides.

“We look forward to the next phase of our partnership as we continue to work with Sheba to help deliver safe and reliable remote care to even more patients.”

 

Fertility

Paracetamol use may impact future fertility, studies suggest

Published

on

Paracetamol use in pregnancy was not linked to autism or ADHD, while separate research found reproductive differences in girls exposed before birth.

One study analysed health records from more than 120,000 children and found no increased risk of autism following prenatal paracetamol exposure.

A separate analysis of nearly 100,000 children also found no increased risk of ADHD among those born to mothers who used the painkiller during pregnancy.

Researchers from the Hong Kong Hospital Authority examined electronic health records covering pregnancies between January 2001 and December 2023.

The autism analysis included 124,333 children, who were nine years old on average and split almost evenly between males and females. There were 3,445 autism diagnoses, representing 2.8 per cent of the group.

The ADHD analysis involved 97,285 children, who were seven years old on average and also split evenly between males and females. There were 5,168 ADHD diagnoses, representing 5.3 per cent.

Women prescribed paracetamol during pregnancy were more likely to be older and have pre-existing conditions including psychiatric disorders, as well as reasons for taking the drug such as infection, fever or chronic pain.

No association was found between prenatal paracetamol exposure and either autism or ADHD.

The findings did not differ according to the trimester in which paracetamol was taken or whether use was intermittent or daily. Advanced maternal age, defined as pregnancy in women over 35, did not alter the findings.

The researchers wrote: “Paracetamol remains a safe and essential analgesic [pain reliever] and antipyretic [fever reducer] during pregnancy, whereas alternatives, such as NSAIDs and opioids carry well-documented risks.

“Unwarranted reluctance to use paracetamol could lead to undertreatment of pain and fever, or the use of more harmful alternatives, both posing risks to the pregnancy and developing fetus.”

The authors said women should assess paracetamol use with guidance from their doctor.

A separate study involving 685 pregnant women without pre-existing conditions and 302 infant daughters found associations between prenatal paracetamol exposure and differences in reproductive organs and hormone levels.

Researchers from Copenhagen University Hospital enrolled the women during their first trimester and assessed them during the first trimester, third trimester and again when their babies were three months old.

At around three months, infants experience a temporary rise in reproductive hormones sometimes called mini-puberty.

Pregnant participants completed questionnaires every two weeks about their use of pain medicines including paracetamol. Infant girls underwent ultrasound scans of their reproductive organs and blood tests to measure hormone levels.

Researchers also examined a separate group of 1,210 girls followed from infancy to adolescence whose mothers reported paracetamol use during the third trimester.

Three-month-old girls exposed to paracetamol before birth had an average 40 per cent smaller ovarian volume, 13 per cent smaller uterine volume and 23 per cent fewer ovarian follicles.

Girls exposed during the first trimester also had lower levels of Anti-Müllerian hormone, a marker of ovarian function.

Among the older girls, those exposed before birth were more likely to have smaller uteruses at puberty and smaller ovaries during their teenage years.

Dr Margit Bistrup Fischer, lead study author and postdoctoral researcher in the Department of Growth and Reproduction at Rigshospitalet hospital in Denmark, said: “Animal studies have demonstrated that impaired formation of ovarian follicles can lead to reduced fertility and earlier reproductive aging.

“Whether the differences observed in our study have implications for fertility and age at menopause in humans remains unknown and will require long-term follow-up of the girls in our cohort.”

She cautioned that women who had used paracetamol during pregnancy “should not be alarmed by our findings”, as the study found associations rather than direct causation and outcomes for individual women and children are unclear.

“Importantly, our study does not evaluate whether [acetaminophen] causes reproductive problems, nor does it provide evidence that prenatal exposure affects future fertility or age at menopause,” she said.

“Although we observed similar associations in an independent cohort, long-term follow-up is needed to determine whether these early-life differences have any clinical significance later in life.”

Continue Reading

Wellness

Pregnant women prioritised as NHS rolls out flu vaccine

Published

on

Pregnant women are among the first groups offered the NHS flu vaccine this winter, which has been updated to better match the subclade K strain.

Schoolchildren are also being prioritised and, like pregnant women, can receive the vaccine from September because they can catch and spread flu easily.

Protecting them also helps others, including younger siblings and grandparents.

Other eligible groups, including people aged 65 and over, will be able to receive a free NHS flu vaccine from October and should receive an invitation by phone or post.

Dr Amanda Doyle from NHS England said: “Last year’s flu season came early and was made worse by a new variant, which had a major impact for patients and put enormous pressure on urgent and emergency care services across the country.

“With the NHS experiencing its busiest summer on record, staff have started preparing for this winter earlier than ever – and with services already under significant pressure, it is vital that everyone offered the vaccine comes forward.”

Last winter’s flu season began more than a month earlier than usual as a new mutated strain circulated.

The strain was sometimes referred to as “Super flu”, although this is not a medical term and does not mean the virus is harder to treat. The name reflected that people had yet to build up immunity against it.

Flu vaccines are updated each year to better match the influenza viruses expected to circulate. These viruses continually mutate, so experts must predict how they are likely to change.

This winter’s vaccine includes changes intended to provide a better match for subclade K.

It remains unclear when flu will begin circulating widely this winter or how severe the season will be. Experts often look at flu activity in southern hemisphere countries such as Australia and New Zealand for indications of how the UK season could develop.

Their flu season peaks in July or August. Australia has recorded fewer cases than last year, while New Zealand has experienced high numbers.

Everyone is at risk of catching flu, regardless of age or how fit and healthy they are.

Doyle said: “Flu can really knock you for six, and for some children and pregnant women it can mean becoming seriously ill or ending up in hospital.”

The flu vaccine cannot give you flu. Instead, it helps the body know how to fight the virus.

Children aged two and over receive a nasal spray version, while adults receive an injection. One dose is needed ahead of winter.

Free NHS flu vaccines are available through pharmacies, GPs and schools. People who are not eligible for a free vaccination can pay around £10 to £20.

Schoolchildren and pregnant women can receive a free NHS flu vaccine from September onwards.

From October, free vaccination will also be available to children aged two or older who have not yet started school, people aged 65 and over, those with certain long-term health conditions, care home residents and carers of older or disabled people, including those receiving a carer’s allowance.

It will also be available to people living with someone who has a weakened immune system and those experiencing homelessness or staying in a homeless hostel or night shelter.

More adults will also be offered vaccination against respiratory syncytial virus (RSV), a virus that attacks the lungs, this winter.

From September, adults with certain pre-existing health conditions, such as chronic lung disease, will be invited for the RSV vaccine when they turn 65 rather than waiting until 75.

Continue Reading

Pregnancy

New universal heart attack definition could transform care for women

Published

on

Four leading cardiovascular health groups have agreed new guidance for healthcare professionals assessing patients with suspected heart attacks.

Historically, some less common forms of heart attack, which evidence shows affect women far more than men, have been classified as less important, with treatment and care often worse as a result.

Experts said women had been receiving less effective treatments that did not always target the specific cause of their heart attack and could even make them more unwell.

The changes were announced in Munich on the opening day of the annual congress of the European Society of Cardiology (ESC).

Professor Bryan Williams, chief scientific and medical officer of the British Heart Foundation, said: “This is a landmark moment, a radical shift in how we define and diagnose heart attacks worldwide which will transform people’s care.

“For decades, women have missed out on accurate diagnoses and treatment.

“This focus on finding less common causes of heart attacks, which predominantly affect women, should help to change that. It could be life-changing for huge numbers of women in the UK and worldwide.”

The new guidance upgrades three types of heart attack that can be up to 10 times more common in women and are often caused by childbirth, exercise and emotional stress.

The most serious cases, previously known as “type 1” and now classed as “primary” heart attacks, had previously prioritised those caused by a clot blocking blood flow to the heart.

Other forms can involve reduced blood flow for different reasons, including the tightening or tearing of coronary arteries. These can be more likely to be missed or treated less urgently.

The guidance also introduces a lower diagnostic threshold for women based on levels of troponin, a protein released into the blood when the heart is injured and damaged.

Previously, women were expected to meet the same troponin threshold as men to receive a diagnosis.

Williams said the streamlined heart attack categories would also help patients understand the cause of their heart attack and what comes next.

The three upgraded types are coronary artery spasm, coronary embolism and spontaneous coronary artery dissection (SCAD).

Coronary artery spasm involves the tightening of an artery, which can deprive the heart muscle of blood and oxygen. It can be caused by emotional stress, exercise or extreme cold.

Coronary embolism occurs when a blood clot or fatty deposit travels to a coronary artery and causes a blockage.

SCAD is caused by a tear in a coronary artery. Around 80 per cent of cases occur in women, and it often happens during or soon after pregnancy.

Professor Nicholas Mills, a cardiologist at the University of Edinburgh who led the international taskforce behind the guidance, said it was “the first time that we’ve had a truly global approach to aligning how we diagnose what is probably the most important diagnosis there is”.

He said: “It kills so many people, and we’ve never got everyone together around the world to agree how we’re going to describe it, classify it, explain it to our patients.

“Our job now is to implement this as widely as possible. It’s just as relevant for the UK as it is for any other country around the world. It is a revolution. It’s going to make care better for patients.”

Mills said there had been “unintended systematic bias against women”, including through the use of the key blood test for diagnosing heart attacks at an average level, which picks up all men but misses some women.

He said: “This is used for all types of heart attack in every emergency department in the world, and we want to make sure that it’s used correctly.”

The guidance was drawn up by the ESC, the American College of Cardiology, the American Heart Association and the World Heart Federation.

Continue Reading

Trending

Copyright © 2025 Aspect Health Media Ltd. All Rights Reserved.